NTI Nippon Compressor Nebulizer Machine
৳ 2,100.00
Specification of NTI Nebulizer
- Product Name: NTI Nebulizer Machine
- One–button operation system
- Perfect for your convenient daily use
- Liquid Capacity: 6ml
- The sound level is Less than 65 dB
- Fit for home use and travel use
Call for detail: 01842-756014, 01755-024567
Buy NTI Nebulizer Machine in BD
The NTI nebulizer machine is a small, portable device that converts liquid medication into a mist, which can then be inhaled. This makes it much easier to take medication, and it is also very effective. The machine is designed for people of all ages, and it incorporates Japanese technology.
Features and Benefits of NTI Nebulizer Machine
1. Converts liquid medication into a mist: This is a big benefit, as it makes it much easier to take medication.
2. Portable: The machine is small and portable, so it can be taken wherever you go.
3. Effective: The machine is very effective at preventing asthma attacks.
4. Designed for people of all ages: The machine is designed for people of all ages so that anyone can use it.
5. Incorporates Japanese technology: The machine incorporates Japanese technology, which makes it very reliable.
If you or a loved one suffers from asthma, the NTI nebulizer machine is a great option. It is effective, portable, and easy to use. Order yours today and experience the difference of targeted mist therapy!
Be the first to review “NTI Nippon Compressor Nebulizer Machine”
Related products
-8%
Nebulizer Machine
Original price was: ৳ 2,400.00.৳ 2,200.00Current price is: ৳ 2,200.00.
Nebulizer Machine
৳ 3,000.00
-9%
Out of stock
Nebulizer Machine
Original price was: ৳ 3,500.00.৳ 3,200.00Current price is: ৳ 3,200.00.
-10%
Nebulizer Machine
Original price was: ৳ 6,500.00.৳ 5,850.00Current price is: ৳ 5,850.00.
-4%
Nebulizer Machine
Original price was: ৳ 4,800.00.৳ 4,600.00Current price is: ৳ 4,600.00.
৳ 2,200.00
General Health
৳ 2,200.00
Medical Equipment
Owgels Compressor Nebulizer WH-702 | Portable Nebulizer Machine
৳ 3,500.00
Reviews
There are no reviews yet.